Four things to know:
1. Anika Therapeutics is an orthopedic and regenerative medicine company specializing in treatments using its proprietary hyaluronic acid technology.
2. At the summit, orthopedic surgeon Alberto Gobbi, MD, will present findings from a 10-year follow-up study of patients treated with Hyalofast HA scaffold with bone marrow aspirate concentrate in a one-step surgical procedure.
3. Dr. Gobbi’s session will also compare Hyalofast to autologous chondrocyte implantation and matrix autologous chondrocyte implantation, two-step surgeries requiring cell activation.
4. Hyalofast been used to treat more than 15,000 patients and is pending regulatory approval in the U.S. following its FastTRACK phase 3 trial, which is currently enrolling patients across the U.S. and Europe.
More articles on biologics:
Biogennix expands team: 4 things to know
9 key players in the global platelet rich plasma market
3 things to know about the global orthopedic biomaterials market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
